Bill Taranto, President of the GHI Fund at Merck — Corporate Ventures for Integrated Healthcare Solutions
Bill Taranto President of Global Health Innovation Fund at Merck, Bill Taranto: Corporate Ventures for Integrated Digital Healthcare Solutions

Bill Taranto is President of the Global Health Innovation Fund at Merck (https://www.merckghifund.com/taranto.html) and founding partner since inception in 2010.

Merck Global Health Innovation Fund is a corporate venture fund that uses a healthcare ecosystem approach. It invests globally in companies with proven business models or technologies where Merck can enhance value creation and accelerate revenue growth.

Merck GHI manages $500M per an evergreen-model and invests in digital health and other segments. It has invested in over 60 portfolio companies and had over 20 exits. The company invests in segments such as Therapy Planning, Care Management and Health Analytics & AI. They also fund eClinical Trials, enabling technologies, and eClinical Trials.

Bill has over 30 years experience in the health care industry, including more than 20 years of investing in healthcare.

Bill also has over a decade’s worth of experience in management operations.

Bill is the Chairman of Merck Innovative Ventures Board. This group manages the identification of and funding of portfolio companies. He is also the Chairman of GHI Fund LLC Management Board.

Bill worked at Johnson & Johnson for 18 years in various roles, including venture capital, marketing and sales, as well as business development. Bill worked in investment banking for eight years before joining J&J. Bill holds a Bachelor in Business Administration from St. Bonaventure University.

Source: